News Release Details
Entegris Reports Strong Second-Quarter Results
Second-quarter sales were
For the first half of fiscal 2017, sales of
Quarterly Financial Results Summary
(in thousands, except per share data)
GAAP Results |
Q2-2017 |
Q2-2016 |
Q1-2017 |
|||
Net sales |
|
|
|
|||
Operating income |
|
|
|
|||
Operating margin |
18.0% |
15.3% |
16.0% |
|||
Net income |
|
|
|
|||
Diluted earnings per share (EPS) |
|
|
|
|||
Non-GAAP Results |
||||||
Non-GAAP adjusted operating income |
|
|
|
|||
Adjusted operating margin |
22.4% |
19.0% |
19.5% |
|||
Non-GAAP net income |
|
|
|
|||
Non-GAAP EPS |
|
|
|
Third-Quarter Outlook
For the third quarter ending
Segment Results
As of
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases, and materials and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC solutions purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport, and deliver critical liquid chemistries and substrates for a broad set of applications in the semiconductor industry and other high-technology industries.
Second-Quarter Results Conference Call Details
Management's slide presentation concerning the results for the second quarter, which may be referred to during the call, will be posted on the investor relations section of http://investor.entegris.com/ Thursday morning before the call.
ABOUT
Non-GAAP Information
The Company's condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in
Forward-Looking Statements
Certain information contained in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "intends," "estimate," "forecast," "project," "should," "may," "will," "would" or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include those about future period guidance; future sales, net income, net income per diluted share, non-GAAP EPS, non-GAAP net income, expenses and other financial metrics; our performance relative to our markets; market and technology trends; the development of new products and the success of their introductions; the Company's capital allocation strategy; our ability to execute on our strategies; and other matters. These forward-looking statements are based on current management expectations and assumptions only as of the date of this press release, are not guarantees of future performance and involve substantial risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, but are not limited to, weakening of global and/or regional economic conditions, generally or specifically in the semiconductor industry, which could decrease the demand for our products and solutions; our ability to meet rapid demand shifts; our ability to continue technological innovation and introduce new products to meet our customers' rapidly changing requirements; our concentrated customer base; our ability to identify, effect and integrate acquisitions, joint ventures or other transactions; our ability to protect and enforce intellectual property rights; operational, political and legal risks of our international operations; our dependence on sole source and limited source suppliers; the increasing complexity of certain manufacturing processes; raw material shortages and price increases; changes in government regulations of the countries in which we operate; fluctuation of currency exchange rates; fluctuations in the market price of
Condensed Consolidated Statements of Operations (In thousands, except per share data) (Unaudited) |
|||||||
Three months ended |
|||||||
|
|
|
|||||
Net sales |
|
|
|
||||
Cost of sales |
178,699 |
163,847 |
177,781 |
||||
Gross profit |
150,303 |
139,205 |
139,596 |
||||
Selling, general and administrative expenses |
52,985 |
53,597 |
50,492 |
||||
Engineering, research and development expenses |
27,221 |
28,146 |
27,239 |
||||
Amortization of intangible assets |
11,007 |
11,062 |
10,945 |
||||
Operating income |
59,090 |
46,400 |
50,920 |
||||
Interest expense, net |
8,103 |
9,051 |
8,393 |
||||
Other (income) expense, net |
(46) |
(1,054) |
902 |
||||
Income before income tax expense |
51,033 |
38,403 |
41,625 |
||||
Income tax expense |
11,042 |
5,513 |
9,111 |
||||
Net income |
|
|
|
||||
Basic net income per common share: |
|
|
|
||||
Diluted net income per common share: |
|
|
|
||||
Weighted average shares outstanding: |
|||||||
Basic |
141,696 |
140,953 |
141,501 |
||||
Diluted |
143,508 |
141,723 |
143,315 |
Condensed Consolidated Statements of Operations (In thousands, except per share data) (Unaudited) |
|||||
Six months ended |
|||||
|
|
||||
Net sales |
|
|
|||
Cost of sales |
356,480 |
316,165 |
|||
Gross profit |
289,899 |
253,911 |
|||
Selling, general and administrative expenses |
103,477 |
101,553 |
|||
Engineering, research and development expenses |
54,460 |
54,048 |
|||
Amortization of intangible assets |
21,952 |
22,351 |
|||
Operating income |
110,010 |
75,959 |
|||
Interest expense, net |
16,496 |
18,200 |
|||
Other expense (income), net |
856 |
(1,729) |
|||
Income before income tax expense |
92,658 |
59,488 |
|||
Income tax expense |
20,153 |
10,386 |
|||
Net income |
|
|
|||
Basic net income per common share: |
|
|
|||
Diluted net income per common share: |
|
|
|||
Weighted average shares outstanding: |
|||||
Basic |
141,599 |
140,867 |
|||
Diluted |
143,411 |
141,547 |
Condensed Consolidated Balance Sheets (In thousands) (Unaudited) |
||||
|
|
|||
ASSETS |
||||
Cash and cash equivalents |
|
|
||
Accounts receivable, net |
171,113 |
165,675 |
||
Inventories |
194,155 |
183,529 |
||
Deferred tax charges and refundable income taxes |
16,716 |
20,140 |
||
Other current assets |
21,374 |
24,398 |
||
Total current assets |
808,993 |
800,131 |
||
Property, plant and equipment, net |
341,146 |
321,562 |
||
|
355,178 |
345,269 |
||
Intangible assets |
206,182 |
217,548 |
||
Deferred tax assets |
8,622 |
8,022 |
||
Other assets |
7,322 |
7,000 |
||
Total assets |
|
|
||
LIABILITIES AND SHAREHOLDERS' EQUITY |
||||
Long-term debt, current maturities |
|
|
||
Accounts payable |
56,961 |
61,617 |
||
Accrued liabilities |
75,275 |
83,530 |
||
Income tax payable |
18,786 |
16,424 |
||
Total current liabilities |
251,022 |
261,571 |
||
Long-term debt, excluding current maturities |
435,910 |
484,677 |
||
Other liabilities |
58,242 |
54,066 |
||
Shareholders' equity |
982,269 |
899,218 |
||
Total liabilities and shareholders' equity |
|
|
Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) |
||||||||
Three months ended |
Six months ended |
|||||||
|
|
|
|
|||||
Operating activities: |
||||||||
Net income |
|
|
|
|
||||
Adjustments to reconcile net income to net |
||||||||
Depreciation |
14,411 |
13,825 |
28,388 |
27,525 |
||||
Amortization |
11,007 |
11,062 |
21,952 |
22,351 |
||||
Stock-based compensation expense |
4,039 |
3,505 |
7,909 |
6,366 |
||||
Provision for deferred income taxes |
(215) |
(720) |
3,207 |
(931) |
||||
Other |
6,497 |
4,408 |
10,130 |
9,204 |
||||
Changes in operating assets and liabilities: |
||||||||
Trade accounts and notes receivable |
4,514 |
(29,300) |
(3,032) |
(36,099) |
||||
Inventories |
(8,422) |
1,609 |
(13,837) |
(11,389) |
||||
Accounts payable and accrued liabilities |
10,177 |
23,065 |
(13,313) |
13,555 |
||||
Income taxes payable and refundable income taxes |
4,209 |
1,133 |
2,957 |
407 |
||||
Other |
(1,049) |
(278) |
1,725 |
(1,553) |
||||
Net cash provided by operating activities |
85,159 |
61,199 |
118,591 |
78,538 |
||||
Investing activities: |
||||||||
Acquisition of business net of cash acquired |
(20,000) |
— |
(20,000) |
— |
||||
Acquisition of property and equipment |
(20,302) |
(14,325) |
(42,492) |
(32,144) |
||||
Other |
25 |
837 |
211 |
(1,658) |
||||
Net cash used in investing activities |
(40,277) |
(13,488) |
(62,281) |
(33,802) |
||||
Financing activities: |
||||||||
Payments on long-term debt |
(25,000) |
(25,000) |
(50,000) |
(25,000) |
||||
Issuance of common stock |
1,864 |
2,380 |
2,905 |
2,380 |
||||
Taxes paid related to net share settlement of |
(664) |
(136) |
(5,239) |
(2,203) |
||||
Other |
(5,000) |
42 |
(9,270) |
(3,482) |
||||
Net cash used in financing activities |
(28,800) |
(22,714) |
(61,604) |
(28,305) |
||||
Effect of exchange rate changes on cash |
(1,606) |
4,343 |
4,540 |
7,487 |
||||
Increase (decrease) in cash and cash equivalents |
14,476 |
29,340 |
(754) |
23,918 |
||||
Cash and cash equivalents at beginning of period |
391,159 |
344,403 |
406,389 |
349,825 |
||||
Cash and cash equivalents at end of period |
|
|
|
|
Segment Information (In thousands) (Unaudited) |
||||||||||
Three months ended |
Six months ended |
|||||||||
Net sales |
|
|
|
|
|
|||||
Specialty Chemicals and Engineered |
|
|
|
|
|
|||||
Microcontamination Control |
104,407 |
91,584 |
100,055 |
204,462 |
169,203 |
|||||
Advanced Materials Handling |
103,421 |
99,686 |
102,887 |
206,308 |
187,984 |
|||||
Total net sales |
|
|
|
|
|
Three months ended |
Six months ended |
|||||||||
Segment profit |
|
|
|
|
|
|||||
Specialty Chemicals and Engineered |
|
|
|
|
|
|||||
Microcontamination Control |
36,484 |
28,566 |
35,581 |
72,065 |
46,706 |
|||||
Advanced Materials Handling |
19,573 |
22,519 |
18,276 |
37,849 |
41,430 |
|||||
Total segment profit |
90,231 |
79,999 |
81,997 |
172,228 |
139,466 |
|||||
Amortization of intangibles |
11,007 |
11,062 |
10,945 |
21,952 |
22,351 |
|||||
Unallocated expenses |
20,134 |
22,537 |
20,132 |
40,266 |
41,156 |
|||||
Total operating income |
|
|
|
|
|
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit (In thousands) (Unaudited) |
||||||||||
Three months ended |
Six months ended |
|||||||||
|
|
|
|
|
||||||
Net sales |
|
|
|
|
|
|||||
Gross profit-GAAP |
|
|
|
|
|
|||||
Adjustments to gross profit: |
||||||||||
Impairment of equipment |
1,966 |
— |
— |
1,966 |
— |
|||||
Adjusted gross profit |
|
|
|
|
|
|||||
Gross margin - as a % of net sales |
45.7 |
% |
45.9 |
% |
44.0 |
% |
44.8 |
% |
44.5 |
% |
Adjusted gross margin - as a % of net sales |
46.3 |
% |
45.9 |
% |
44.0 |
% |
45.2 |
% |
44.5 |
% |
Reconciliation of GAAP Segment Profit to Adjusted Operating Income (In thousands) (Unaudited) |
||||||||||
Three months ended |
Six months ended |
|||||||||
Segment profit-GAAP |
|
|
|
|
|
|||||
Specialty Chemicals and Engineered Materials |
|
|
|
|
|
|||||
Microcontamination Control |
36,484 |
28,566 |
35,581 |
72,065 |
46,706 |
|||||
Advanced Materials Handling |
19,573 |
22,519 |
18,276 |
37,849 |
41,430 |
|||||
Total segment profit |
90,231 |
79,999 |
81,997 |
172,228 |
139,466 |
|||||
Amortization of intangible assets |
11,007 |
11,062 |
10,945 |
21,952 |
22,351 |
|||||
Unallocated expenses |
20,134 |
22,537 |
20,132 |
40,266 |
41,156 |
|||||
Total operating income |
|
|
|
|
|
|||||
Segment profit margin-GAAP |
||||||||||
Specialty Chemicals and Engineered Materials |
28.2 |
% |
25.9 |
% |
24.6 |
% |
26.4 |
% |
24.1 |
% |
Microcontamination Control |
34.9 |
% |
31.2 |
% |
35.6 |
% |
35.2 |
% |
27.6 |
% |
Advanced Materials Handling |
18.9 |
% |
22.6 |
% |
17.8 |
% |
18.3 |
% |
22.0 |
% |
Three months ended |
Six months ended |
|||||||||
Adjusted segment profit |
|
|
|
|
|
|||||
Specialty Chemicals and Engineered Materials |
|
|
|
|
|
|||||
Microcontamination Control 1 |
37,927 |
28,566 |
35,581 |
73,508 |
46,706 |
|||||
Advanced Materials Handling 2 |
21,859 |
22,519 |
18,276 |
40,135 |
41,430 |
|||||
Total adjusted segment profit |
93,960 |
79,999 |
81,997 |
175,957 |
139,466 |
|||||
Amortization of intangible assets 3 |
— |
— |
— |
— |
— |
|||||
Unallocated expenses |
20,134 |
22,537 |
20,132 |
40,266 |
41,156 |
|||||
Total adjusted operating income |
|
|
|
|
|
|||||
Adjusted segment profit margin |
||||||||||
Specialty Chemicals and Engineered Materials |
28.2 |
% |
25.9 |
% |
24.6 |
% |
26.4 |
% |
24.1 |
% |
Microcontamination Control |
36.3 |
% |
31.2 |
% |
35.6 |
% |
36.0 |
% |
27.6 |
% |
Advanced Materials Handling |
21.1 |
% |
22.6 |
% |
17.8 |
% |
19.5 |
% |
22.0 |
% |
1 Adjusted segment profit for Microcontamination Control for the three and six months ended |
2 Adjusted segment profit for Advanced Material Handling for the three and six months ended |
3 Adjusted amortization of intangible assets excludes amortization expense of |
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA (In thousands) (Unaudited) |
||||||||||
Three months ended |
Six months ended |
|||||||||
|
|
|
|
|
||||||
Net sales |
|
|
|
|
|
|||||
Net income |
|
|
|
|
|
|||||
Adjustments to net income: |
||||||||||
Income tax expense |
11,042 |
5,513 |
9,111 |
20,153 |
10,386 |
|||||
Interest expense, net |
8,103 |
9,051 |
8,393 |
16,496 |
18,200 |
|||||
Other (income) expense, net |
(46) |
(1,054) |
902 |
856 |
(1,729) |
|||||
GAAP - Operating income |
59,090 |
46,400 |
50,920 |
110,010 |
75,959 |
|||||
Severance |
559 |
— |
— |
559 |
— |
|||||
Impairment of equipment |
3,170 |
— |
— |
3,170 |
— |
|||||
Amortization of intangible assets |
11,007 |
11,062 |
10,945 |
21,952 |
22,351 |
|||||
Adjusted operating income |
73,826 |
57,462 |
61,865 |
135,691 |
98,310 |
|||||
Depreciation |
14,411 |
13,825 |
13,977 |
28,388 |
27,525 |
|||||
Adjusted EBITDA |
|
|
|
|
|
|||||
Adjusted operating margin |
22.4 |
% |
19.0 |
% |
19.5 |
% |
21.0 |
% |
17.2 |
% |
Adjusted EBITDA - as a % of net sales |
26.8 |
% |
23.5 |
% |
23.9 |
% |
25.4 |
% |
22.1 |
% |
Reconciliation of GAAP Net Income to Non-GAAP Earnings per Share (In thousands, except per share data) (Unaudited) |
|||||||||||
Three months ended |
Six months ended |
||||||||||
|
|
|
|
|
|||||||
GAAP net income |
|
|
|
|
|
||||||
Adjustments to net income: |
|||||||||||
Severance |
559 |
— |
— |
559 |
— |
||||||
Impairment of equipment |
3,170 |
— |
— |
3,170 |
— |
||||||
Gain on sale of equity investment |
— |
(38) |
— |
— |
(156) |
||||||
Amortization of intangible assets |
11,007 |
11,062 |
10,945 |
21,952 |
22,351 |
||||||
Tax effect of adjustments to net income and discrete items |
(5,821) |
(3,624) |
(2,705) |
(8,526) |
(7,390) |
||||||
Non-GAAP net income |
|
|
|
|
|
||||||
Diluted earnings per common share |
|
|
|
|
|
||||||
Effect of adjustments to net income |
|
|
|
|
|
||||||
Diluted non-GAAP earnings per common share |
|
|
|
|
|
Contact:
VP of Corporate Relations
T + 978 436 6500
irelations@entegris.com
View original content:http://www.prnewswire.com/news-releases/entegris-reports-strong-second-quarter-results-300495010.html
SOURCE
News Provided by Acquire Media